JNJ's three largest insider shareholders as of September 09, 2026 are Alex Gorsky (Chairman, Ceo, 766.58K shares), Joaquin Duato (Ceo And Chairman Of The Board, 275.97K shares), Joaquin Duato (Ceo And Chairman Of The Board, 275.97K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Alex Gorsky | Chairman, Ceo | 766,584 | 0 | 766,584 | 38.4% | 18 Jan, 2023 |
| 2 | Joaquin Duato | Ceo And Chairman Of The Board | 275,967 | 0 | 275,967 | 13.8% | 14 Aug, 2026 |
| 3 | Jennifer L Taubert | Evp, Wwc. Innovative Medicine | 194,451 | 0 | 194,451 | 9.7% | 18 Aug, 2026 |
| 4 | Michael H Ullmann | Exec Vp, General Counsel | 158,835 | 0 | 158,835 | 8.0% | 16 Feb, 2022 |
| 5 | Kathryn E Wengel | Evp, Chief To And Risk Officer | 114,288 | 0 | 114,288 | 5.7% | 12 Jun, 2026 |
| 6 | Peter Fasolo | Exec Vp, Chief Hr Officer | 112,076 | 0 | 112,076 | 5.6% | 15 Feb, 2024 |
| 7 | Thibaut Mongon | Exec Vp, Ww Chair, Cons Health | 65,915 | 0 | 65,915 | 3.3% | 15 Feb, 2023 |
| 8 | Ashley Mcevoy | Evp, Ww Chair, Medtech | 52,038 | 0 | 52,038 | 2.6% | 25 Aug, 2023 |
| 9 | Mathai Mammen | Evp, Pharm, Rd | 41,934 | 0 | 41,934 | 2.1% | 16 Feb, 2022 |
| 10 | William Hait | Officer | 38,647 | 0 | 38,647 | 1.9% | 15 Feb, 2024 |
| 11 | James D. Swanson | Evp, Cio | 25,698 | 0 | 25,698 | 1.3% | 18 Feb, 2026 |
| 12 | Timothy Schmid | Evp, Ww Chair, Medtech | 25,447 | 0 | 25,447 | 1.3% | 04 Sep, 2026 |
| 13 | John C Reed | Evp, Innovative Medicine, Rd | 24,911 | 0 | 24,911 | 1.2% | 04 May, 2026 |
| 14 | Robert J Decker | Vp Corporate Controller | 23,682 | 0 | 23,682 | 1.2% | 03 Mar, 2026 |
| 15 | Vanessa Broadhurst | Evp, Global Corp Affairs | 23,003 | 0 | 23,003 | 1.2% | 21 Jul, 2026 |
| 16 | Kristen Mulholland | Evp, Chief Hr Officer | 19,830 | 0 | 19,830 | 1.0% | 18 Feb, 2026 |
| 17 | Elizabeth Forminard | Evp, Chief Legal Officer | 16,994 | 0 | 16,994 | 0.9% | 07 Aug, 2026 |
| 18 | Joseph J Wolk | Exec Vp, Cfo | 14,000 | 0 | 14,000 | 0.7% | 18 Feb, 2026 |
| 19 | John G Morikis | Director | 1,849 | 0 | 1,849 | 0.1% | 01 Dec, 2025 |
| 20 | Mark A Weinberger | Director | 1,000 | 0 | 1,000 | 0.1% | 12 Dec, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 02 Sep, 2026 | Timothy Schmid | Evp, Ww Chair, Medtech | Acquired M | 11,070 | $131.94 | $1.46Mn | 36,517 | Direct |
| 02 Sep, 2026 | Timothy Schmid | Evp, Ww Chair, Medtech | Disposed S | 11,070 | $274.74 | $3.04Mn | 25,447 | Direct |
| 02 Sep, 2026 | Timothy Schmid | Evp, Ww Chair, Medtech | Acquired M | 22,527 | $151.41 | $3.41Mn | 47,974 | Direct |
| 02 Sep, 2026 | Timothy Schmid | Evp, Ww Chair, Medtech | Disposed S | 22,527 | $274.74 | $6.19Mn | 25,447 | Direct |
| 02 Sep, 2026 | Timothy Schmid | Evp, Ww Chair, Medtech | Disposed M | 11,070 | $0.00 | $0 | 0 | Direct |
| 02 Sep, 2026 | Timothy Schmid | Evp, Ww Chair, Medtech | Disposed M | 22,527 | $0.00 | $0 | 0 | Direct |
| 17 Aug, 2026 | Jennifer L Taubert | Evp, Wwc. Innovative Medicine | Acquired M | 15,000 | $115.67 | $1.74Mn | 209,451 | Direct |
| 17 Aug, 2026 | Jennifer L Taubert | Evp, Wwc. Innovative Medicine | Disposed S | 15,000 | $263.36 | $3.95Mn | 194,451 | Direct |
| 17 Aug, 2026 | Jennifer L Taubert | Evp, Wwc. Innovative Medicine | Disposed M | 15,000 | $0.00 | $0 | 28,712 | Direct |
| 06 Aug, 2026 | Elizabeth Forminard | Evp, Chief Legal Officer | Acquired M | 9,344 | $131.94 | $1.23Mn | 32,912 | Direct |
| 05 Aug, 2026 | Joaquin Duato | Ceo And Chairman Of The Board | Disposed S | 41,957 | $258.06 | $10.83Mn | 282,490 | Direct |
| 05 Aug, 2026 | Joaquin Duato | Ceo And Chairman Of The Board | Disposed S | 6,523 | $258.74 | $1.69Mn | 275,967 | Direct |
| 06 Aug, 2026 | Elizabeth Forminard | Evp, Chief Legal Officer | Disposed S | 9,344 | $257.76 | $2.41Mn | 23,568 | Direct |
| 06 Aug, 2026 | Elizabeth Forminard | Evp, Chief Legal Officer | Disposed S | 6,574 | $255.93 | $1.68Mn | 16,994 | Direct |
| 06 Aug, 2026 | Elizabeth Forminard | Evp, Chief Legal Officer | Disposed M | 9,344 | $0.00 | $0 | 0 | Direct |
| 20 Jul, 2026 | Vanessa Broadhurst | Evp, Global Corp Affairs | Acquired M | 11,129 | $129.51 | $1.44Mn | 34,132 | Direct |
| 20 Jul, 2026 | Vanessa Broadhurst | Evp, Global Corp Affairs | Acquired M | 11,925 | $131.94 | $1.57Mn | 46,057 | Direct |
| 20 Jul, 2026 | Vanessa Broadhurst | Evp, Global Corp Affairs | Disposed S | 23,054 | $251.27 | $5.79Mn | 23,003 | Direct |
| 20 Jul, 2026 | Vanessa Broadhurst | Evp, Global Corp Affairs | Disposed M | 11,129 | $0.00 | $0 | 0 | Direct |
| 20 Jul, 2026 | Vanessa Broadhurst | Evp, Global Corp Affairs | Disposed M | 11,925 | $0.00 | $0 | 0 | Direct |